A new class of viral inhibitor.
D019380:Anti-HIV Agents / Q000138:chemical synthesis / Q000737:chemistry*; D015703:Antigens, CD / Q000737:chemistry / Q000502:physiology; D001665:Binding Sites; D015704:CD4 Antigens / Q000737:chemistry* / Q000502:physiology; D002460:Cell Line; D015195:Drug Design; D006678:HIV / Q000187:drug effects / Q000502:physiology; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000138:chemical synthesis / Q000737:chemistry; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000737:chemistry*
D019380:Anti-HIV Agents; D015703:Antigens, CD; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D009842:Oligopeptides; D010446:Peptide Fragments